Source: Annual Congress 2006 - Cystic fibrosis lung disease: molecules images and drugs
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
C. Aldridge, A. De Soyza, C. M. A. Khan, P. A. Corris (Newcastle, United Kingdom). Proteomics based investigations of burkholderia cepacia complex species. Eur Respir J 2006; 28: Suppl. 50, 1972

Member's Comments

No comment yet.

Related content which might interest you: Phenotypic assessment of potential Burkholderia cepacia virulence associated determinants Source: Eur Respir J 2003; 22: Suppl. 45, 503s Year: 2003 Antimicrobial activity of N-acetylcysteine against Stenotrophomonas maltophilia and Burkholderia cepacia complex grown in planktonic phase and in biofilm Source: International Congress 2017 – How can microbiology and translational research help physicians? Year: 2017 Epidemiology of Burkholderia cepacia complex colonisation in cystic fibrosis patients Source: Eur Respir J 2004; 23: 851-856 Year: 2004 The relevance of epidemic ET-12 B. cenocepacia lipopolysaccharide (LPS) structure and cytokine induction capacity compared to other burkholderia cepacia complex species Source: Eur Respir J 2006; 28: Suppl. 50, 485s Year: 2006 Burkholderia cepacia complex infection in Czech patients with cystic fibrosis Source: Eur Respir J 2003; 22: Suppl. 45, 503s Year: 2003 TNF and LTA gene polymorphisms in cystic fibrosis patients with Burkholderia cepacia complex (Bcc) Source: Virtual Congress 2021 – Clinical effects of CFTR modulatory therapy and lung inflammation in children with cystic fibrosis Year: 2021 The role of MBL in B. cepacia infections in CF patients Source: Eur Respir J 2005; 26: Suppl. 49, 403s Year: 2005 Burkholderia cepacia: current clinical issues, environmental controversies and ethical dilemmas Source: Eur Respir J 2001; 17: 295-301 Year: 2001 Low transmission risk of Pseudomonas aeruginosa in a bronchiectasis clinic based on the knowledge of bacterial population biology Source: Eur Respir J, 53 (3) 1802191; 10.1183/13993003.02191-2018 Year: 2019 Variation in hydrogen cyanide production between different strains of Pseudomonas aeruginosa Source: Eur Respir J 2011; 38: 409-414 Year: 2011 Broad spectrum of virulence of pseudomonas aeruginosa clones characterized in a murine airway infection model Source: Annual Congress 2013 –Bacterial, fungal and mycobacterial infections Year: 2013 Development and characterisation of a multi-species COPD biofilm Source: Virtual Congress 2020 – New insight into the pathogenesis of chronic lung diseases: asthma, COPD and others Year: 2020 Molecular mechanisms and virulence of colistin-resistant klebsiella pneumoniae Source: International Congress 2016 – Microbiological issues and translational research in respiratory infections Year: 2016 A proteomics approach for the identification of species-specific immunogenic proteins in the Mycobacterium abscessus complex Source: International Congress 2019 – Infection and inflammation in cystic fibrosis Year: 2019 Clinical and microbiological characteristics of Pseudomonas aeruginosa isolates from patients with COPD Source: Eur Respir J 2005; 26: Suppl. 49, 58s Year: 2005 Shared Pseudomonas aeruginosa genotypes are common in Australian cystic fibrosis centres Source: Eur Respir J 2013; 41: 1091-1100 Year: 2013 Molecular characterization of M. tuberculosis complex strains from a drug resistance survey in Albania Source: Annual Congress 2013 –Tuberculosis: clinical epidemiology and public health Year: 2013 Molecular genetic characteristics of Pseudomonas aeruginosa strains isolated from children with cystic fibrosis in Moscow. Source: Virtual Congress 2021 – Cystic fibrosis in children: various aspects Year: 2021